Vitamin D dosing strategies among jordanians with hypovitaminosis d: A randomized controlled trial

Journal of Pharmacy Practice

Volumn 30, Issue 2, 2017, Pages 172-179

  Khawaja, Nahla ^a   Liswi, Mohammed ^a   El Khateeb, Mohammed ^a   Hyassat, Dana ^a   Bajawi, Dalila ^a   Elmohtaseb, Mayada ^a   Alkhateeb, Hussein ^a   Ajlouni, Kamel ^a  

^a UNIVERSITY OF JORDAN   (Jordan)

Author keywords

Cholecalciferol; Hypovitaminosis d; Jordan; Therapy

Indexed keywords

COLECALCIFEROL; ERGOCALCIFEROL; 25-HYDROXYVITAMIN D; VITAMIN D;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CALCIUM BLOOD LEVEL; CHEMILUMINESCENCE IMMUNOASSAY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FISH; HUMAN; JORDANIAN; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; OPEN STUDY; RANDOMIZED CONTROLLED TRIAL; SUNLIGHT; VITAMIN BLOOD LEVEL; VITAMIN D INTOXICATION; VITAMIN DEFICIENCY; ANALOGS AND DERIVATIVES; BLOOD; DIETARY SUPPLEMENT; DOSE RESPONSE; JORDAN; VITAMIN D DEFICIENCY; YOUNG ADULT;

ADULT; CHOLECALCIFEROL; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; JORDAN; MALE; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 85018690759     PISSN: 08971900     EISSN: 15311937     Source Type: Journal    
DOI: 10.1177/0897190015626334     Document Type: Article

References (57)

1. DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 2004;80(6 suppl): 1689s-1696s.
2. Jones G, Strugnell SA, DeLuca HF. Current understanding of the molecular actions of vitamin D. Physiol Rev. 1998;78(4): 1193-1231.
3. Wei MY, Giovannucci EL. Vitamin D and multiple health outcomes in the Harvard cohorts. Mol Nutr Food Res. 2010;54(8): 1114-1126.
4. Garland CF, Garland FC, Gorham ED, et al. The role of vitamin D in cancer prevention. Am J Publ Health. 2006;96(2):252-261.
5. Teegarden D, Donkin SS. Vitamin D: Emerging new roles in insulin sensitivity. Nutr Res Rev. 2009;22(1):82-92.
6. Verdoia M, Schaffer A, Sartori C, et al. Vitamin D deficiency is independently associated with the extent of coronary artery disease. Eur J Clin Investig. 2014;44(7):634-642.
7. Ascherio A, Munger KL, White R, et al. Vitamin D as an early predictor of multiple sclerosis activity and progression. JAMA Neurol. 2014;71(3):306-314.
8. Schottker B, Haug U, Schomburg L, et al. Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study. Am J Clin Nutr. 2013;97(4):782-793.
9. Schottker B, Ball D, Gellert C, Brenner H., Serum 25-hydroxyvitamin D levels and overall mortality. A systematic review and meta-Analysis of prospective cohort studies. Ageing Res Rev. 2013;12(2):708-718.
10. Palacios C, Gonzalez L. Is vitamin D deficiency a major global public health problem? J Steroid Biochem Mol Biol. 2014;144(pt A):138-145.
11. Hoteit M, Al-Shaar L, Yazbeck C, et al. Hypovitaminosis D in a sunny country: Time trends, predictors, and implications for practice guidelines. Metabolism. 2014;63(7):968-978.
12. Ardawi MS, Sibiany AM, Bakhsh TM, et al. High prevalence of vitamin D deficiency among healthy Saudi Arabian men: Relationship to bone mineral density, parathyroid hormone, bone turnover markers, and lifestyle factors. Osteoporos Int. 2012;23(2): 675-686.
13. Saliba W, Barnett O, Stein N, et al. The longitudinal variability of serum 25(OH)D levels. Eur J Intern Med. 2012;23(4):e106-e111.
14. El Maghraoui A, Ouzzif Z, Mounach A, et al. Hypovitaminosis D and prevalent asymptomatic vertebral fractures in Moroccan postmenopausal women. BMC Womens Health. 2012;12:11.
15. Meddeb N, Sahli H, Chahed M, et al. Vitamin D deficiency in Tunisia. Osteoporos Int. 2005;16(2):180-183.
16. Badawi A, Arora P, Sadoun E, et al. Prevalence of vitamin d insufficiency in Qatar: A systematic review. J Public Health Res. 2012;1(3):229-235.
17. Kaykhaei MA, Hashemi M, Narouie B, et al. High prevalence of vitamin D deficiency in Zahedan, southeast Iran. Ann Nutr Metab. 2011;58(1):37-41.
18. Khuri-Bulos N, Lang RD, Blevins M, et al. Vitamin D deficiency among newborns in Amman, Jordan. Glob J Health Sci. 2013; 6(1):162-171.
19. Abdul-Razzak KK, Ajlony MJ, Khoursheed AM, et al. Vitamin D deficiency among healthy infants and toddlers: A prospective study from Irbid, Jordan. Pediatr Int. 2011;53(6):839-845.
20. Nichols EK, Khatib IM, Aburto NJ, et al. Vitamin D status and associated factors of deficiency among Jordanian children of preschool age. Eur J Clin Nutr. 2015;69(1):90-95.
21. Nichols EK, Khatib IM, Aburto NJ, et al. Vitamin D status and determinants of deficiency among non-pregnant Jordanian women of reproductive age. Eur J Clin Nutr. 2012;66(6): 751-756.
22. Batieha A, Khader Y, Jaddou H, et al. Vitamin D status in Jordan: dress style and gender discrepancies. Ann Nutr Metab. 2011; 58(1):10-18.
23. Mallah EM, Hamad MF, Elmanaseer MA, et al. Plasma concentrations of 25-hydroxyvitamin D among Jordanians: Effect of biological and habitual factors on vitamin D status. BMC Clin Pathol. 2011;11:8.
24. Mishal AA. Effects of different dress styles on vitamin D levels in healthy young Jordanian women. Osteoporosis Int. 2001;12(11): 931-935.
25. Gharaibeh MA, Stoecker BJ. Assessment of serum 25(OH)D concentration in women of childbearing age and their preschool children in Northern Jordan during summer. Eur J Clin Nutr. 2009; 63(11):1320-1326.
26. Neer RM. The evolutionary significance of vitamin D, skin pigment, and ultraviolet light. Am J Phys Anthropol. 1975;43(3): 409-416.
27. McGrath JJ, Saha S, Burne TH, et al. A systematic review of the association between common single nucleotide polymorphisms and 25-hydroxyvitamin D concentrations. J Steroid Biochem Mol Biol. 2010;121(1-2):471-477.
28. Bu FX, Armas L, Lappe J, et al. Comprehensive association analysis of nine candidate genes with serum 25-hydroxy vitamin D levels among healthy Caucasian subjects. Hum Genet. 2010; 128(5):549-556.
29. Serdula MK, Nichols EK, Aburto NJ, et al; Jordan Fortification Working Group. Micronutrient status in Jordan: 2002 and 2010. Eur J Clin Nutr. 2014;68(10):1124-1128.
30. Institute of Medicine. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: What clinicians need to know. J Clin Endocrinol Metab. 2011; 96(1):53-58.
31. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al; Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2011;96(7):1911-1930.
32. Holick MF. Vitamin D deficiency. N Eng. J Med. 2007;357(3): 266-281.
33. Armas LA, Hollis BW, Heaney RP. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab. 2004;89(11):5387-5391.
34. Kruk ME, Schwalbe N. The relation between intermittent dosing and adherence: preliminary insights. Clin Ther. 2006;28(12): 1989-1995.
35. Ish-Shalom S, Segal E, Salganik T, et al. Comparison of daily, weekly, and monthly vitamin D3 in ethanol dosing protocols for two months in elderly hip fracture patients. J Clin Endocrinol Metab. 2008;93(9):3430-3435.
36. Saadi HF, Dawodu A, Afandi BO, et al. Efficacy of daily and monthly high-dose calciferol in vitamin D-deficient nulliparous and lactating women. Am J Clin Nutr. 2007;85(6):1565-1571.
37. Chel V, Wijnhoven HA, Smit JH, et al. Efficacy of different doses and time intervals of oral vitamin D supplementation with or without calcium in elderly nursing home residents. Osteoporos Int. 2008;19(5):663-671.
38. Whiting SJ, Calvo MS. Correcting poor vitamin D status: do older adults need higher repletion doses of vitamin D3 than younger adults? Mol Nutr Food Res. 2010;54(8):1077-1084.
39. Bhutto A, Morley JE. The clinical significance of gastrointestinal changes with aging. Curr Opin Clin Nutr Metab Care. 2008; 11(5):651-660.
40. Bryant GA, Koenigsfeld CF, Lehman NP, et al. A retrospective evaluation of response to vitamin D supplementation in obese versus nonobese patients. J Pharm Pract. 2015;28(6):543-547.
41. Vieth R. Why the optimal requirement for vitamin D3 is probably much higher than what is officially recommended for adults. J Steroid Biochem Mol Biol. 2004;89-90(1-5):575-579.
42. Singh G, Bonham AJ. A predictive equation to guide vitamin D replacement dose in patients. J Am Board Fam Med. 2014;27(4): 495-509.
43. Ginde AA, Liu MC, Camargo CA Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988- 2004. Arch Intern Med. 2009;169(6):626-632.
44. Parikh SJ, Edelman M, Uwaifo GI, et al. The relationship between obesity and serum 1, 25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab. 2004;89(3):1196-1199.
45. Konradsen S, Ag H, Lindberg F, et al. Serum 1, 25-dihydroxy vitamin D is inversely associated with body mass index. Eur J Nutr. 2008;47(2):87-91.
46. Hypponen E, Power C. Vitamin D status and glucose homeostasis in the 1958 British birth cohort: The role of obesity. Diabetes Care. 2006;29(10):2244-2246.
47. Wortsman J, Matsuoka LY, Chen TC, et al. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72(3):690-693.
48. Chapuy MC, Preziosi P, Maamer M, et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int. 1997;7(5):439-443.
49. Holick MF, Siris ES, Binkley N, et al. Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab. 2005; 90(6):3215-3224.
50. Kuchuk NO, Pluijm SM, van Schoor NM, et al. Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons. J Clin Endocrinol Metab. 2009;94(4):1244-1250.
51. Sai AJ, Walters RW, Fang X, et al. Relationship between vitamin D, parathyroid hormone, and bone health. J Clin Endocrinol Metab. 2011;96(3):e436-e446.
52. Jubiz W, Canterbury JM, Reiss E, et al. Circadian rhythm in serum parathyroid hormone concentration in human subjects: correlation with serum calcium, phosphate, albumin, and growth hormone levels. J Clin Invest. 1972;51(8):2040-2046.
53. Calvo MS, Kumar R, Heath H III. Elevated secretion and action of serum parathyroid hormone in young adults consuming high phosphorus, low calcium diets assembled from common foods. J Clin Endocrinol Metab. 1988;66(4):823-829.
54. Pramyothin P, Holick MF. Vitamin D supplementation: guidelines and evidence for subclinical deficiency. Curr Opin Gastroenterol. 2012;28(2):139-150.
55. Whitner JB. Re: A predictive equation to guide vitamin D replacement dose in patients. J Am Board Fam Med. 2015;28(1):160.
56. Hibler E, Hu C, Jurutka P, et al. Effect of over-The-counter vitamin D supplementation on circulating 25-hydroxyvitamin D concentration. Cancer Prev Res. 2011;4(10 suppl):b103.
57. Holick MF, Matsuoka LY, Wortsman J. Age, vitamin D, and solar ultraviolet. Lancet. 1989;2(8671):1104-1105.